- Report
- August 2025
- 358 Pages
Global
From €3206EUR$3,600USD£2,796GBP
From €2271EUR$2,550USD£1,980GBP
- Report
- April 2026
- 174 Pages
Global
From €4319EUR$4,850USD£3,766GBP
- Report
- March 2026
- 200 Pages
Global
From €4007EUR$4,500USD£3,495GBP
- Report
- October 2025
- 80 Pages
Global
From €4319EUR$4,850USD£3,766GBP
- Report
- July 2025
- 80 Pages
Asia Pacific
From €5299EUR$5,950USD£4,621GBP
- Report
- May 2025
- 120 Pages
United States
From €3518EUR$3,950USD£3,067GBP
- Report
- August 2025
- 85 Pages
United States
From €3117EUR$3,500USD£2,718GBP
- Report
- June 2025
- 300 Pages
Asia Pacific
From €3445EUR$3,869USD£3,005GBP
- Report
- March 2026
- 134 Pages
Europe
From €3562EUR$4,000USD£3,106GBP
- Report
- March 2026
- 138 Pages
Asia Pacific
From €3562EUR$4,000USD£3,106GBP
- Report
- March 2026
- 164 Pages
North America
From €3562EUR$4,000USD£3,106GBP
- Report
- October 2025
- 86 Pages
Middle East
From €4319EUR$4,850USD£3,766GBP
- Report
- October 2025
- 91 Pages
Middle East
From €4319EUR$4,850USD£3,766GBP
- Report
- October 2025
- 99 Pages
United States
From €4319EUR$4,850USD£3,766GBP
- Report
- October 2025
- 98 Pages
United States
From €4319EUR$4,850USD£3,766GBP
- Report
- May 2024
- 321 Pages
Global
From €5163EUR$6,001USD£4,350GBP
- Report
- February 2019
- 300 Pages
Global
From €4006EUR$4,499USD£3,494GBP
- Report
- October 2022
- 185 Pages
Global
From €4274EUR$4,799USD£3,727GBP
- Report
- January 2021
- 350 Pages
Global
From €4274EUR$4,799USD£3,727GBP

The Real World Evidence (RWE) market within the context of E-Healthcare is a rapidly growing sector. It is a form of evidence-based medicine that uses data from real-world sources such as patient records, claims data, and observational studies to inform healthcare decisions. RWE can be used to assess the safety and effectiveness of treatments, identify new indications for existing treatments, and inform healthcare policy. It can also be used to assess the cost-effectiveness of treatments and to identify potential areas of improvement in healthcare delivery.
RWE is increasingly being used by healthcare providers, payers, and pharmaceutical companies to inform their decisions. It is also being used by researchers to gain insights into the effectiveness of treatments and to identify potential areas of improvement in healthcare delivery.
Some companies in the RWE market include IBM Watson Health, Optum, Flatiron Health, and Evidation Health. Show Less Read more